Effects of Giant Salamander Protein Peptide and Its Maillard Reaction Product on Blood Glucose, Lipid Levels, Immune Function,and Anti-fatigue Activity in Vivo

Objective: To investigate the impact of giant salamander protein peptide (CGS) and its Maillard reaction product (CGSXyU) on lowering blood glucose and lipid levels in type Ⅱ diabetic mice and enhancing immunomodulatory functions in immunosuppressed mice, and anti-fatigue effects in normal mice. Methods: Mice were randomly assigned to a blank control group, a model control group, a positive control group (200 mg/kg metformin), a low-dose sample group (CGS/CGSXyU-L, 50 mg/kg), and a high-dose sample group (CGS/CGSXyU-H, 200 mg/kg). Following the successful induction of diabetes with 100 mg/kg alloxan, the mice underwent gavage treatment for 3 weeks, after which their fasting blood glucose levels, serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels were measured. Mice were randomly assigned to a blank control group, a model control group, a positive control group (50 mg/kg levamisole), a low-dose sample group (CGS/CGSXyU-L, 50 mg/kg), and a high-dose sample group (CGS/CGSXyU-H, 200 mg/kg). Following successful modeling with 100 mg/kg cyclophosphamide, the mice underwent gavage for three weeks, during which their body weights were recorded, and changes in organ indices and cytokine levels were assessed. Similarly, mice were randomly divided into a blank control group, a positive control group (200 mg/kg taurine), a low-dose sample group (CGS/CGSXyU-L, 50 mg/kg), and a high-dose sample group (CGS/CGSXyU-H, 200 mg/kg). They were subjected to gavage for four weeks, after which the mice's weight-bearing swimming time, urea nitrogen levels, creatine kinase activity, serum lactate levels, and antioxidant enzyme activity were measured. Results: The CGS/CGSXyU-L/H treated group of mice exhibited reduced fasting blood glucose concentration, serum total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C), along with elevated high-density lipoprotein cholesterol (HDL-C) levels. CGSXyU-H significantly enhanced the body weight (P<0.05), organ index, and levels of immune cytokines (IL-6, IL-10, TNF-α, IFN-γ) in immunocompromised mice. The CGS/CGSXyU-L/H treatment group demonstrated increased time in weight-bearing swimming, reduced creatine kinase activity and serum lactate levels, the BUN level in the CGS-H and CGSXyU-L/H groups decreased, while the GSH-Px activity significantly increased in the CGSXyU-H group (P<0.05), the SOD activity in the CGS-H and CGSXyU-L/H groups also increased. Conclusion: The protein peptides from Andrias davidianus and their Maillard reaction products regulate blood glucose and lipid metabolism in type Ⅱ diabetes mice, bolster immune function in immunocompromised mice, and effectively improve the anti-fatigue capacity in normal mice.

Institutions

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2024-10-01
DOI
https://doi.org/10.13386/j.issn1002-0306.2024060317
Primary Topic
Advanced Glycation End Products research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of Giant Salamander Protein Peptide and Its Maillard Reaction Product on Blood Glucose, Lipid Levels, Immune Function,and Anti-fatigue Activity in Vivo

SHILAP Revista de lepidopterología
Advanced Glycation End Products research
article

Effects of Giant Salamander Protein Peptide and Its Maillard Reaction Product on Blood Glucose, Lipid Levels, Immune Function,and Anti-fatigue Activity in Vivo

article en

Abstract

Objective: To investigate the impact of giant salamander protein peptide (CGS) and its Maillard reaction product (CGSXyU) on lowering blood glucose and lipid levels in type Ⅱ diabetic mice and enhancing immunomodulatory functions in immunosuppressed mice, and anti-fatigue effects in normal mice. Methods: Mice were randomly assigned to a blank control group, a model control group, a positive control group (200 mg/kg metformin), a low-dose sample group (CGS/CGSXyU-L, 50 mg/kg), and a high-dose sample group (CGS/CGSXyU-H, 200 mg/kg). Following the successful induction of diabetes with 100 mg/kg alloxan, the mice underwent gavage treatment for 3 weeks, after which their fasting blood glucose levels, serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels were measured. Mice were randomly assigned to a blank control group, a model control group, a positive control group (50 mg/kg levamisole), a low-dose sample group (CGS/CGSXyU-L, 50 mg/kg), and a high-dose sample group (CGS/CGSXyU-H, 200 mg/kg). Following successful modeling with 100 mg/kg cyclophosphamide, the mice underwent gavage for three weeks, during which their body weights were recorded, and changes in organ indices and cytokine levels were assessed. Similarly, mice were randomly divided into a blank control group, a positive control group (200 mg/kg taurine), a low-dose sample group (CGS/CGSXyU-L, 50 mg/kg), and a high-dose sample group (CGS/CGSXyU-H, 200 mg/kg). They were subjected to gavage for four weeks, after which the mice's weight-bearing swimming time, urea nitrogen levels, creatine kinase activity, serum lactate levels, and antioxidant enzyme activity were measured. Results: The CGS/CGSXyU-L/H treated group of mice exhibited reduced fasting blood glucose concentration, serum total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C), along with elevated high-density lipoprotein cholesterol (HDL-C) levels. CGSXyU-H significantly enhanced the body weight (P<0.05), organ index, and levels of immune cytokines (IL-6, IL-10, TNF-α, IFN-γ) in immunocompromised mice. The CGS/CGSXyU-L/H treatment group demonstrated increased time in weight-bearing swimming, reduced creatine kinase activity and serum lactate levels, the BUN level in the CGS-H and CGSXyU-L/H groups decreased, while the GSH-Px activity significantly increased in the CGSXyU-H group (P<0.05), the SOD activity in the CGS-H and CGSXyU-L/H groups also increased. Conclusion: The protein peptides from Andrias davidianus and their Maillard reaction products regulate blood glucose and lipid metabolism in type Ⅱ diabetes mice, bolster immune function in immunocompromised mice, and effectively improve the anti-fatigue capacity in normal mice.

SHILAP Revista de lepidopterología
Lishui University (CN), Zhejiang Gongshang University (CN)
Good health and well-being
Openalex Percentile: Top 59%
Advanced Glycation End Products research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.